3-(benzylamino)-4-(cyclohexylamino)-n-(2-(piperazin-1-yl)ethyl)benzenesulfonamide derivatives and related ferrostatin-1 analogues as cell death inhibitors for treating e.g. stroke
US-11339124-B2 · May 24, 2022 · US
This page is not indexed by search engines while we improve data quality.
Hofmans Sam patents
Hofmans Sam is listed as an inventor on 4 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Hofmans Sam |
| Total patents | 4 |
| First publication | Nov 2, 2017 |
| Latest publication | May 24, 2022 |
Notable patents
Publications ranked by popularity score, then publication date.
3-(benzylamino)-4-(cyclohexylamino)-n-(2-(piperazin-1-yl)ethyl)benzenesulfonamide derivatives and related ferrostatin-1 analogues as cell death inhibitors for treating e.g. stroke
US-2021094909-A1 · Apr 1, 2021 · US
3,4-diaminobenzenesulfonamide derivatives for inhibiting cell death
US-9862678-B2 · Jan 9, 2018 · US
3,4-diaminobenzenesulfonamide derivatives for inhibiting cell death
US-2017313653-A1 · Nov 2, 2017 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Vib Vzw | 4 |
| Univ Antwerpen | 4 |
| Univ Gent | 4 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07C311/39 | 4 |
| C07C311/40 | 4 |
| C07D213/38 | 4 |
| A61P25/28 | 4 |
| C07D295/027 | 2 |